GO
Loading...

Health Care Equipment and Supplies

More

  • July 24- Boston Scientific Corp, which makes medical equipment, on Thursday reported a slightly higher-than-expected quarterly profit as improvements in its heart device business helped drive revenue up 4 percent.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Midday Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Allergan rose$. 59 or. 4 percent, to $164.97. Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Boston Scientific Corp. rose$. 09 or. 7 percent, to $12.94.

  • Early Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Allergan rose$. 09 or. 1 percent, to $164.47. Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Boston Scientific Corp. rose$. 07 or. 5 percent, to $12.92.

  • Novartis to use Google technology for eye care Tuesday, 15 Jul 2014 | 8:09 AM ET

    Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease. Terms of the agreement between the companies were not detailed in a statement released Tuesday by Novartis.

  • Midday Glance: Medical Devices companies Monday, 14 Jul 2014 | 1:29 PM ET

    Allergan fell$. 34 or. 2 percent, to $166.09. Baxter International Inc. rose$. 03 or percent, to $76.62. Boston Scientific Corp. fell$. 13 or. 9 percent, to $13.17.

  • Early Glance: Medical Devices companies Monday, 14 Jul 2014 | 10:47 AM ET

    Allergan fell$. 82 or. 5 percent, to $165.61. Baxter International Inc. rose$. 20 or. 3 percent, to $76.79. Boston Scientific Corp. fell$. 10 or. 8 percent, to $13.19.

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. The company's two units supplied pelvic mesh products to one of the manufacturers named in the lawsuit and is indemnifying that manufacturer on certain claims.

  • In preparatory documents posted on the agency's website on Tuesday, FDA reviewers said laparoscopic power morcellator devices, which are used to treat uterine fibroids, allow for less invasive surgeries, shorter recovery time and fewer wound site infections.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • WASHINGTON, June 27- The U.S. Food and Drug Administration said on Friday it has approved MannKind Corp's inhaled insulin, Afrezza, capping an arduous journey for the company and its octogenarian founder, Alfred Mann. It acts more rapidly than injectable insulins such as Eli Lilly and Co's Humalog and Novo Nordisk's NovoLog.

  • AMSTERDAM/ SAN FRANCISCO, June 26- Dutch healthcare and lighting company Philips said on Thursday it was teaming up with Salesforce, one of the first cloud-computing companies in the United States, to offer online management of chronic diseases.

  • SAN FRANCISCO, June 23- For decades, medical technology firms have searched for ways to let diabetics check blood sugar easily, with scant success.

  • BOSTON, June 20- Medtronic Inc, the world's largest stand-alone medical device maker, said on Friday it was the victim of a cyber attack last year.